The study of signal transduction pathways for mechanisms of apoptosis and proliferation has significantly advanced our understanding of human cancer, subsequently leading to more effective treatments. Discoveries of growth factors and oncogenes, especially those that function through phosphorylation on tyrosine residues, have greatly benefited our appreciation of the biology of cancer. The regulation of proliferation and apoptosis through phosphorylation via tyrosine kinases and phosphatases is discussed, as well as the contributions of other systems, such as serine and threonine kinases and phosphatases. Receptors with seven-transmembrane domains, steroid hormones, genes, and "death domains" will also be discussed. This review attempts to compare the regulation of the growth of normal tissues and cancers with an effort to highlight the current knowledge of these factors in the growth regulation of oral/oropharyngeal cancers. Despite the strides made in our understanding of growth regulation in human cancers, the study of oral/oropharyngeal cancer specifically lags behind. More research must be done to further our understanding of oral cancer biology, if we are to develop better, more effective treatment protocols.
References
1.
Adari H., Lowy DR, Willumsen BM, Der CJ, McCormick F. (1988). Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science240:514-521.
2.
Arends MJ, Wyllie AH (1991). Apoptosis: mechanisms and roles in pathology. lnt Rev Exp Pathol52:223-254.
3.
Armstrong DK, Kaufmann SH, Ottaviano YL, Furuya Y., Buckley JA, Issacs JT, et al. (1994). Epidermal growth factor mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res54:5280-5283.
4.
Baker SJ, Reddy EP (1996). Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene12:1-9.
5.
Baker SI, Markowitz S., Fearon ER, Willson JKV, Vogelstein B. (1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science249:912-915.
6.
Berchuck A., Rodriguez G., Kamel A., Soper JT, Clarke-Pearson DL, Bast RC Jr (1990). Expression of epidermal growth factor receptor and HER-2/Neu in normal and neoplastic cervix, vulva, and vagina. Obstet Gynecol76:381-387.
7.
Berra E., Diaz-Meco MT, Dominguez I., Municio MM, Sanz L., Lozano J., et al. (1993). Protein kinase C isoform is critical for mitogenic signal transduction. Cell74:555-563.
8.
Bertics P.), Gill GN ( 1985). Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor. J Biol Chem260:14642-14647.
9.
Birnbaumer L. (1992). Receptor-to-effector signaling through G proteins: roles for β γ dimers as well as a subunit. Cell71:1069-1072.
10.
Bishop MJ (1991) Molecular themes in oncogenesis. Cell64:235-248.
11.
Boni-Schnetzler M., Pilch PF (1987). Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding. Proc Natl Acad Sci USA84:7832-7836.
12.
Boring CC, Squires TS, Tong T. ( 1992). Cancer statistics. Cancer J Clin42:19-38.
13.
Brabyn CJ, Franks DJ Kleine LP (1994). Long-term exposure to epidermal growth factor results in apoptosis in T51 B. Biochem Cell Biol72:429-438.
14.
Bravo R., Burckhardt J., Curran T., Muller R. (1985). Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes. EMBO J4:1193-1197.
15.
Briskin KB, Fady C., Wang M., Lichtenstein A. (1996). Apoptotic inhibition of head and neck squamous cell carcinoma cells by TNF a. Arch Otolaryngol Head Neck Surg122:559-563.
16.
Buchkovich K., Duffy LA, Harlow E. ( 1989). The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell58:1097-1105.
17.
Buday L., Downward J. ( 1993). Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell73:611-620.
18.
Bulera SJ, Saftler CA, Pitot HC (1996). The translational inhibitor cycloheximide represses growth factor depletion-induced apoptosis in an alb-SV40T transgenic rat liver cell line. Hepatology23:1591-1601.
19.
Burgering BM, Bos JL (1995). Regulation of Ras-mediated signaling: more than one way to skin a cat. Trends Biochem Sci20:18-22.
20.
Bursch W., Kleine L., Tenniswood M. (1990). The biochemistry of cell death by apoptosis. Biochem Cell Biol68:1071-1074.
21.
Buscail L., Delesque N., Esteve JP, Saint-Laurent N., Prats H., Clerc P., et al. (1994). Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by the human SSTR1 and SSTR2 somatostatin receptor subtypes. Proc Natl Acad Sci USA91:2315-2319.
22.
Cacace AM, Guadagno SN, Krauss RS, Fabbro D., Weinstein IB (1993). The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene8: 2095-2104.
23.
Cai H., Erhardt P., Troppmaier J., Diaz-Meco MT, Sithanandam G., Rapp UR, et al. (1993). Hydrolysis of phosphatidylcholine couples Ras to activation of raf protein kinase during mitogenic signal transduction. Mol Cell Biol13:7645-7651.
24.
Campana D., Coustan-Smith E., Manabe A., Buschle M., Raimondi SC, Behm FG, et al. (1993). Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of Bcl-2 protein. Blood811025-1031.
25.
Candi E., Melino G., De Laurenzi V., Piacentini M., Guerrieri P., Spinedi A., et al. (1995). Tamoxifen and somatostatin affect tumors by inducing apoptosis. Cancer Lett96:141-145.
26.
Cantley LC, Auger KR, Carpenter C., Duckworth B., Graziani A., Kapeller R., et al. (1991). Oncogenes and signal transduction. Cell64:281-302.
27.
Cao L., Faha B., Dembski M., Tsai LH, Harlow E., Dyson N. (1992). Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F Nature355:176-179.
Carpentier JL ( 1993). The journey of the insulin receptor into the cell: from cellular biology to pathophysiology. Histochem100:169-184.
30.
Chajry N., Martin PM, Pages G., Cochet C., Afdel K., Berthois Y. (1994). Relationship between the MAP kinase activity and the dual effect of EGF on A431 cell proliferation. Biochem Biophys Res Commun203:984-990.
31.
Chen IK, Lin SS (1993). Stimulation or inhibition of A431 cell growth by EGF is directly correlated with receptor tyrosine kinase concentration but not with PLC gamma activity. Life Sciences53:635-642.
32.
Chen-Levy Z. Cleary ML (1990). Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. ) Biol Chem265:4929-4933.
33.
Cicirelli MF, Tonks NK, Diltz CD, Weiel JE, Fischer EH, Krebs EG (1990). Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. Proc Natl Acad Sci USA87:5514-5518.
34.
Cleveland JL, Troppmair J. Packham G., Askew DS, Lloyd P., Gonzales-Garcia M., et al. (1994). v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. Oncogene9:2217-2226.
35.
Cohen P., Holmes CF, Tsukitani Y. (1990). Okadaik acid: a new probe for the study of the cellular regulation. Trends Biochem Sci15:98-102.
36.
Conklin BR, Bourne HR (1993). Structural elements of G alpha subunits that interact with G beta gamma, receptors, and effectors. Cell73:631-641.
37.
Connelly PA, Stern DF (1990). The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade. Proc Natl Acad Sci USA87:6054-6057.
38.
Cook SJ, Beltman J., Cadwallader KA, McMahon M., McCormick F. (1997). Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+dependent signal pathways in Rat-1 cells. J Biol Chem272:13309-13319.
39.
Coughlin SR, Escobedo JA, Williams LT (1989). Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science243:1191-1194.
40.
Cross M., Dexter TM (1991). Growth factors in development, transformation, and tumorigenesis. Cell64:271-280.
41.
De Vos AM, Tong L., Milburn MV, Matias PM, jancarik J. Noguchi S., et al. (1988). Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21. Science239:888-893.
42.
Ebner R., Chen R., Shum L., Lawler S., Zioncheck TF, Lee A., et al. (1993). Cloning of a type TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science260:1344-1348.
43.
Enoch T., Norbury C. (1995). Cellular responses to DNA damage: cell cycle checkpoints, apoptosis and the role of p53 and AMT. Trends Biochem Sci20:426-430.
44.
El-Deiry WS, Tokino T., Velculescu VE, Levy DB, Parsons R., Trent JM, et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell75:817-825.
45.
Escobedo JA, Navankasattusas S., Kavanaugh MW, Milfay D., Fried VA, Williams LT (1991). cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor. Cell65:75-82.
46.
Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H., Brooks M., et al. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell69:119-128.
47.
Fan G., Ma X., Kren BT, Steer CJ (1996). The retinoblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene12:1909-1919.
48.
Fan Z., Lu Y., Wu X., DeBlasio A., Koff A., Mendelsohn J. (1995). Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J Cell Biol131:235-242.
49.
Fantl WJ, Escobedo JA, Martin GA, Turck CW, del Rosario M., McCormick F., et al. (1992). Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell69:413-423.
50.
Feng GS, Hui CC, Pawson T. (1993). SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science259:1607-161 1.
51.
Feramisco JR, Gross M., Kamata T., Rosenberg M., Sweet RW (1984). Microinjection of the oncogene form of the human H-ras (t-24) protein results in rapid proliferation of quiescent cells. Cell38:109-1 17.
52.
Fesus L., Davies PJ, Piacentini M. (1991). Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell Biol56:170-177.
53.
Field JK, Spandidos DA, Malliri A., Gosney JR, Yiagnisis M., Stell PM (1991). Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer64:573-577.
54.
Fields S., Jang SK ( 1990). Presence of a potent transcription activating sequence in the p53 protein. Science249:1046-1049.
55.
Fischer EH, Charbonneau H., Tonks NK ( 1991 Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science253:401-406.
56.
Force T., Bonventre JV, Heidecker G., Rapp U., Avruch J., Kyriakis JM (1994). Enzymatic characteristics of the c-raf-1 protein kinase. Proc Natl Acad Sci USA91:1270-1274.
57.
Frisch SM, Vuori K., Ruoslahti E., Chan-Hui PY (1996). Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol134:793-799.
58.
Frodin M., Peraldi P., Van Obberghen E. (1994). Cyclic AMP activates the mitogen activated protein kinase cascade in PC 12 cells. J Biol Chem269:6207-6214.
59.
Game SM, Stone A., Scully C., Prime SS (1990). Tumour progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-β receptor expression and altered responses to these growth factors. Carcinogenesis11:965-973.
60.
Gill GN, Bertics PJ, Santon JB (1987). Epidermal growth factor and its receptor. Mol Cell Endocrinol51:169-186.
61.
Gille H., Sharrocks AD, Shaw PE ( 1992). Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature358:414-417.
62.
Gilman AG (1987). G proteins: transducers of receptor-generated signals. Ann Rev Biochem56:615-649.
63.
Gjertsen BT, Doskeland SO (1995). Protein phosphorylation in apoptosis. Biochem Biophys Acta1269:187-199.
64.
Goldkorn T., Dressler KA, Muindi J., Radin NS, Mendelsohn J., Menaldino D., et al. (1991). Ceramide stimulates epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells. Evidence that ceramide may mediate sphingosine action. J Biol Chem266:16092-16097.
65.
Guillemin R., Gerich JE (1976). Somatostatin: physiological and clinical significance. Ann Rev Med27:379-388.
66.
Gullick WJ (1990). The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer. Int J Cancer46(Suppl 5):55-61.
67.
Haldar S., Jena N., Croce CM (1994). Antiapoptosis potential of Bcl-2 oncogene by dephosphorylation. Biochem Cell Biol72:455-462.
68.
Haldar S., Chintapalli J., Croce CM (1996). Taxol induced Bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res56:1253-1255.
69.
Harper JW, Adami GR, Wei N., Keyomarsi K., Elledge SJ (1993). The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell75:805-816.
70.
Hierowski MT, Liebow C., DuSapin K., Schally AV (1985). Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line. FEBS Lett179:252-256.
71.
Hofland LJ, Lamberts SWJ (1996). Somatostatin receptor and disease: role of receptor subtypes. Bail Clin Endo Metab10:163-176.
72.
Holbrook SR, Kim SH (1989). Molecular model of the G protein a subunit based on the crystal structure of the HRAS protein. Proc Natl Acad Sci USA86:1751-1755.
73.
Hollstein M., Sidransky D., Vogelstein B., Harris CC (1991). p53 mutations in human cancers. Science253:49-53.
74.
Howe LR, Leevers SJ, Gomez N., Nakielny S., Cohen P., Marshall CJ (1992). Activation of the MAP kinase pathway by the protein kinase raf. Cell71:335-342.
75.
Hoyer D., Lubbert H., Burns C. (1994). Molecular pharmacology of somatostatin receptors. Arch Pharrn350:441-453.
76.
Hunter T. (1987). A thousand and one protein kinases. Cell50:823-829.
77.
Hunter T. ( 1989). Protein-tyrosine phosphatases: the other side of the coin. Cell58:1013-1016.
78.
Hunter T. (1991). Cooperation between oncogenes. Cell64:249-270.
79.
Hunter T., Karin M. (1992). The regulation of transcription by phosphorylation. Cell70:375-387.
80.
Iwata M., Herrington J., Zager RA (1995). Protein synthesis inhibition induces cytoresistance in cultured human proximal tubular (HK-2) cells. Am J Phys286:1154-1163.
81.
Jakus J., Yeudall WA (1996). Growth inhibitory concentrations of EGF induce p21 (WAFl/Cipl) and alter cell cycle control in squamous carcinoma cells. Oncogene12:2369-2376.
82.
Kamer AR (1997). Mediation of multiple signals by epidermal growth factor (PhD thesis). Buffalo, NY: SUNY.
83.
Kaplan DR, Morrison DK, Wong G., McCormick F., Williams LT (1990). PDGF β-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell61:125-133.
84.
Kastan MB (1993). P53: a determinant of the cell cycle response to DNA damage. Adv Exp Med Biol339:291-296.
85.
Kastan MB, Onyekwere O.,Sidransky D., Vogelstein B., Craig RW (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res51:6304-6311.
86.
Kaupmann K., Burns C., Hoyer D. (1993). Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in the brain. FEBS Lett331:53-59.
87.
Kawakami A., Eguchi K., Matsuoka N., Tsuboi M., Kawabe Y., Aoyagi T., et al. (1996). Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor beta 1. Arthritis Rheum39:1267-1276.
88.
Kazlauskas A., Cooper )A. (1989). Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell58:1121-1133.
89.
Kim HK, Kim IW, Zilberstein A., Margolis B., Kim JG, Schlessinger J., et al. (1991). PDGF stimulation of inositol phospholipid hydrolysis requires PLC-γl phosphorylation on tyrosine residues 783 and 1254. Cell65:435-441.
90.
Kim HR, Upadhyay S., Li G., Palmer KC, Deuel TF (1995). Platelet-derived growth factor induces apoptosis in growth-arrested murine fibroblasts. Proc Natl Acad Sci USA92:9500-9504.
91.
Kinoshita T., Yokota T., Arai K., Miyajima A. (1995). Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene10:2207-2212.
92.
Klarlund JK (1985). Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell41:707-717.
93.
Koh JY, Gwag BJ, Lobner D., Choi DW ( 1995). Potentiated necrosis of cultured cortical neurons by neurotrophins. Science268:573-575.
94.
Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., et al. (1993). PKC-alpha activates raf-1 by direct phosphorylation. Nature364:426-428.
95.
Kovacina KS, Yonezawa K., Brautigan DL, Tonks NK, Rapp UR, Roth RA ( 1990). Insulin activates the kinase activity of the raf-1 proto-oncogene by increasing its serine phosphorylation. J Biol Chem265:12115-12118.
96.
Kumar S., Harvey NL (1995). Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett375:169-173.
97.
Kumjian DA, Wahl M., Rhee SG, Daniel TO (1989). Platelet-derived growth factor (PDGF) binding promotes physical association of PDGF receptor with phospholipase C. Proc Natl Acad Sci USA86:8232-8236.
98.
Laiho M., DeCaprio JA, Ludlow JW, Livingston DM, Massague J. (1990). Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell62:175-185.
99.
Lamberts SW, Krenning EP, Reubi JC (1991). The role of somatostatin and its analogs in the diagnosis and treatment of the tumors. Endocr Rev12:450-482.
100.
Landis CA, Masters SB, Spada A., Pace AM, Bourne HR, Vallar L. (1989). GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenyl cyclase in human pituitary tumors. Nature340:692-696.
101.
Lee MT, Liebow C., Kamer AR, Schally AV (1991). Effects of epidermal growth factor and analogues of luteinizing hormone releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors. Proc Natl Acad Sci88:1656-1660.
102.
Lemmon MA, Ladbury JE, Mandiyan V., Zhou M., Schlessinger J. (1994). Independent binding of peptide ligands to the SH2 and SH3 domains of Grb2. J Biol Chem269:31653-31658.
103.
Li N., Batzer A., Daly R., Yajnik V., Skolnik E., Chardin P., et al. (1993). Guanine-nucleotide-releasing factor hsosl binds to Grb2 and links receptor tyrosine kinases to Ras signaling. Nature363:85-88.
104.
Liebow C., Kamer AR (1992). Receptor phosphatases and cancer: models for the therapeutic efficacy of somatostatin and LHRH analogues. Cancer J5:200-207.
105.
Liebow C., Hierowski MT, du Sapin K. (1986). Hormonal control of pancreatic cancer growth. Pancreas1:44-48.
106.
Liebow C., Reilly C., Serrano M., Schally AV (1989). Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci USA86:2003-2007.
107.
Liebow C., Lee MT, Schally AV (1990). Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase. Metabolisrn39(S):163-166.
108.
Liebow C., Lee MT, Kamer AR, Schally AV (1991). Regulation of luteinizing hormone releasing hormone receptor binding by heterologous and autologous receptor stimulated tyrosine phosphorylation. Proc Natl Acad Sci USA88:2244-2248.
109.
Liebow C., Crean DH, Schally AV, Mang TS ( 1993) Peptide analogues induce alterations in progression of pre-malignant lesions as measured by Photofrin fluorescence. Proc Natl Acad Sci USA90:1897-1901.
110.
Liebow C., Crean DH, Lee MT, Kamer AR, Mang TS, Schally AV (1994). Synergistic effects of bombesin and epidermal growth factor on cancers. Proc Natl Acad Sci USA91:3804-3808.
111.
Liu B., Podack ER, Allison JP, Malek TR ( 1996). Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumor. J Immunol156:1117-1125.
112.
Lowenstein EJ, Daly RJ Batzer AG, Li W., Margolis B., Lammers R., et al. (1992). The SH2 and SH3 domain containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell70:431-442.
113.
Macdonald SG, Crews CM, Wu L., Driller J., Clark R., Erikson RL, et al. (1993). Reconstitution of the raf-1-MEK-ERK signal transduction pathway in vitro. Mol Ceit Biol13:6615-6620.
114.
Manning AM, Williams AC, Game SM, Paraskeva C. (1991). Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β: conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene6:1471-1476.
115.
Margolis B. (1992). Proteins with SH2 domains: transducers in tyrosine kinase signaling pathway. Cell Growth Differ3:73-80.
116.
Margolis B., Li N., Koch A., Mohammadi M., Hurwitz DR, Zilberstein A., et al. (1990). The tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-γ. EMBO J9:4375-4380.
117.
Martinez-Gimeno C., Diaz-Meco MT, Dominguez I. Moscat J. (1995). Alterations in levels of different protein kinase C isotypes and their influence on behavior of squamous cell carcinoma of the oral cavity: epsilon PKC, a novel prognostic factor for relapse and survival. Head & Neck17:516-525.
118.
Massague J., Weis-Garcia F. (1996). Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Cancer Surv27:41-64.
119.
May DC, Ross EM, Gilman AG, Smigel MD (1985). Reconstitution of catecholamine-stimulated adenylate cyclase activity using three purified proteins. J Biol Chem260:15829-15833.
120.
McCloskey DE, Armstrong DK, Jackisch C., Davidson NE (1996). Programmed cell death in human breast cancer cells. Rec Prog Horm Res51:493-508.
121.
McConkey DJ Orrenius S., jondal M. (1990). Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J Immunol145:1227-1230.
122.
McConkey DJ, Jondal M., Orrenius S. (1994). The regulation of apoptosis in thymocytes. Biochem Soc Trans22:606-610.
123.
McCormick F. (1995). Ras-related proteins in signal transduction and growth control. Mol Reprod Dev42:500-506.
124.
Meikrantz W., Schlegel R. (1995). Apoptosis and the cell cycle. J Cell Biol58:160-174.
125.
Merlo GR, Basolo F., Fiore L., Duboc L., Hynes NE (1995). p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J Cell Biol128:1185-1196.
126.
Migita K., Eguchi K., Kawabe Y., Nagataki S. (1995). Tyrosine phosphorylation participates in the peripheral T-cell activation and programmed cell death in vivo. Immunol85:550-555.
127.
Milarski KL, Saltier AR (1994). Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol Chem269:21239-21243.
128.
Miller MS, luchau MR, Guengerich FP, Nebert DW, Raucy JL (1996). Drug metabolic enzymes in developmental toxicology. Fund Appl Toxicol34:165-175.
129.
Minami Y., Kono T., Yamada K., Kobayashi N., Kawahara A., Perlmutter RM, et al. (1993). Association of p561ck with IL-2 receptor beta chain is critical for the IL-2-induced activation of p561ck. EMBO J12:759-768.
130.
Miyashita T., Harigai M., Hanada M., Reed JC ( 1994). Identification of a p53-dependent negative response element in the Bcl-2 gene. Cancer Res54:3131-3135.
131.
Montaner S., Ramos A., Perona R., Esteve FS, Carnero A., Lacal JC (1995). Overexpression of PKC ξ in NIH3T3 cells does not induce cell transformation nor tumorigenicity and does not alter NFKB activity. Oncogene10:2213-2220.
132.
Mulcahy LS, Smith MR, Stacey DW (1985). Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature313:241-243.
133.
Mumby MC, Walter G. (1993). Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol Rev73:673-699.
134.
Nebreda AR (1994). Inactivation of MAP kinases. Trends Biochem Sci19:1-2.
135.
Nishibe S., Wahl MI, Hernandez-Sotomayar SMT, Tonks NK, Rhee SG, Carpenter G. (1990). Increase of the catalytic activity of phospholipase C-gamma I by tyrosine phosphorylation. Science253:1253-1256.
136.
Nishizuka Y. (1992). Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science258:607-612.
137.
Ogden GR, Cowpe JG Chisholm DM, Lane DP ( 1994). p53 immunostaining as a marker for oral cancer in diagnostic cytopathology-preliminary report. Cytopathol5:47-53.
138.
Ojeda F., Guarda MI, Maldonado C., Folch H., Diehl H. (1992). Role of protein kinase-C in thymocyte apoptosis induced by irradiation. Int J Radiat Biol61:663-667.
139.
O'Keefe RJ, Crabb ID, Puzas JE, Rosier RN (1994). Effects of transforming growth factor-beta I and fibroblast growth factor on DNA synthesis in growth plate chondrocytes are enhanced by insulin-like growth factor-I. J Orthod Res12:299-310.
140.
Okazaki T., Bell RM, Hannun YA (1989). Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in the cell differentiation. J Biol Chem264:19076-19080.
141.
Oltvai ZN, Milliman CL, Korsmeyer SJ (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell74:609-619.
142.
Otani H., Erdos M., Leonard WJ (1993). Tyrosine kinases regulate apoptosis and Bcl-2 expression in a growth factor-dependent cell line. J Biol Chem268:22733-22736.
143.
Pace AM, Wong YH, Bourne HR (1991). A mutant alpha subunit of Gi2 induces neoplastic transformation of Rat-1 cells. Proc Natl Acad Sci USA88:7031-7035.
144.
Parma J., Duprez L., Van Sande J., Cochaux P., Gervy C., Mockel J., et al. (1993). Somatic mutations in thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature365:649-651.
145.
Pinski J. Halmos G., Kakar SS, Schally AV (1996). Chronic administration of luteinizing hormone releasing hormone antagonist cetrolix decreases gonadotrope responsiveness and pituitary LHRH receptor mRNA levels in rats. Endocrin137:3430-3436.
146.
Porfiri E., McCormick F. (1996). Regulation of epidermal growth factor receptor signaling by phosphorylation of the ras exchange factor hSOSI. J BioL Chem271:5871-5877.
147.
Rabinowich H., Vitolo D., Altarac S., Herberman RB, Whiteside TL (1992). Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. ) J Immunol149:340-349.
148.
Radulovic S., Schally AV, Reile H., Halmos G., Szepeshazi K., Groot K., et al. ( 1994). Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice. Acta Oncol33:693-701.
149.
Rajotte D., Haddad P., Haman A., Cragoe EJ, Hoang T. (1992). Role of protein kinase C and the Na+/H+ antiporter in suppression of apoptosis by granulocyte macrophage colony-stimulating factor and interleukin-3. J Biol Chem267:9980-9987.
150.
Renaud LP, Martin JB, Brazeau P. (1975). Depressant action of TRH, LHRH and somatostatin on activity of central neurons. Nature255:233-235.
151.
Rosenthal A., Lindquist PB, Bringman TS, Goeddel DV, Derynck R. (1996). Expression in rat fibroblasts of a human transforming growth factor-a cDNA results in transformation. Cell46:301-309.
152.
Roy LM, Gittinger CK, Landreth GE (1991). Epidermal growth factor treatment of A431 cells alters the binding capacity and electrophoretic mobility of the cytoskeletally associated epidermal growth factor receptor. J Cell Physiol146:63-72.
153.
Rozakis-Adcock M., McGlade J., Mbamalu G., Pelicci G., Daly R., Li W., et al. (1992). Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature360:689-692.
154.
Rozengurt E. (1990). Bombesin stimulation of mitogenesis. Am Rev Resp Dis142:S11-S15.
155.
Rubin R., Baserga R. (1995). Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis and tumorigenicity. Lab lnvest73:311-331.
156.
Sakai E., Rikimaru K., Ueda M., Matsumoto Y., Ishii N., Enomoto S., et al. (1992). The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma. Int J Cancer52:867-872.
157.
Salomon DS, Kidwell WR (1988). Tumor-associated growth factors in malignant rodent and human mammary epithelial cells. Cancer Treat Res40:363-389.
158.
Sap J., Munoz A., Damm K., Goldberg Y., Ghysdael J., Leutz A., et al. (1986). The c-erbA protein is a high affinity receptor for thyroid hormone. Nature324:635-640.
159.
Sawyer ST, Cohen S. (1981). Enhancement of calcium uptake and phosphatidylinositol turnover by epidermal growth factor in A-431 cells. Biochem20:6280-6286.
160.
Schlessinger J. ( 1994). Cellular signaling by receptor tyrosine kinases. Harvey Lectures89:105-123.
161.
Seuwen K., Pouyssegur J. (1992). G protein-controlled signal transduction pathways and the regulation of cell proliferation. Adv Cancer Res58:75-94.
162.
Sharma K., Patel YC, Srikant CB (1996). Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Molec Endocrinol10:1688-1696.
163.
Simon HU, Yousefi S., Blaser K. (1995). Tyrosine phosphorylation regulates activation and inhibition of apoptosis in human eosinophils and neutrophils. int Arch Allergy lmmunol107:338-339.
164.
Skolnik EY, Margolis B., Mohammadi M., Lowenstein E., Fischer R., Drepps A., et al. (1991). Cloning of P13 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinase. Cell65:83-90.
165.
Smith EB (1989). Primary cancer of the pancreas: a surgical enigma. J Natl Med Assoc81:153-157.
166.
Sorkin A., McKinsey T., Shih W., Kirchhausen T., Carpenter G. (1995). Stoichiometric interaction of the epidermal growth factor receptor with the clathrin-associated protein complex AP-2. J Biol Chem270:619-625.
167.
Spinozzi F., Pagliacci MC, Migliorati G., Moraca R., Grignani F., Riccardi C., et al. (1994). The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leuk Res18:431-439.
168.
Taolin Y., Mui AL, Krystal G., Ihle IN ( 1993). Hematopoietic cell phosphatase associates with the interleukin-3 receptor beta chain and downregulates IL-3-induced tyrosine phosphorylation and mitogenesis. Molec Cell Biol13:7577-7586.
169.
Thurston AW jr, Rhee SG, Shukla SD (1993). Role of guanine nucleotide-binding protein and tyrosine kinase in platelet-activating factor activation of phospholipase C in A431 cells: proposal for dual mechanisms. J Pharm Exp Ther266:1106-)112.
170.
Todd R., Chou MY, Matossian K., Gallagher GT, Donoff RB, Wong DT ( 1991). Cellular sources of transforming growth factor-alpha in human oral cancer. J Dent Res70:917-923.
171.
Tomic S., Greiser U., Lammers R., Kharitonenkov A., Imyanitov E., Ullrich A., et al. (1995). Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C. J Biol Chem270:21277-21284.
172.
Troppmair J., Bruder IT, App H., Cai H., Liptak L., Szeberenyi J., et al. (1992). Ras controls coupling of growth factor receptors and protein kinase C in the membrane to raf-1 and B-raf protein serine kinase in the cytosol. Oncogenes7:1867-1873.
173.
Ullrich A., Schlessinger J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell61:203-212.
174.
Vintermyr OK, Gjertsen BT, Lanotte M., Doskeland SO (1993). Microinjected catalytic subunit of cAMP-dependent protein kinase induces apoptosis in myeloid leukemia (IPC-81) cells. Exp Cell Res206:157-161.
175.
Vogel W., Lammers R., Huang J., Ullrich A. (1993). Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science259:1611-1614.
176.
Vokes EE, Haraf DJ, Mick R., McEvilly JM, Weichselbaum RR (1994). Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J Clin Oncol12:2351-2359.
177.
Walton KM, Dixon JE (1993). Protein tyrosine phosphatases. Ann Rev Biochem62:101-120.
178.
Wang HG, Millan JA, Cox AD, Der CJ, Rapp UR, Beck T., et al. (1995). R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism. J Cell Biol129:1103-1114.
179.
Warri AM, Huovinen RL, Laine AM, Martikainen PM, Harkonen PL (1993). Apoptosis in Toremifeneinduced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer lnst85:1412-1420.
180.
Westendorf JJ, Lammert JM, Jelinek DF (1995). Expression and function of Fas (APO-I/CD95) in patient myeloma cells and myeloma cell lines. Blood85:3566-3576.
181.
White E., Chiou SK, Rao L., Sabbatini P., Lin HJ (1994). Control of p53-dependent apoptosis by El B, Bcl-2 and Ha-ras protein. Cold Spring Harbor Symp Quant Biol59:395-402.
182.
Williams GT, Smith CA, Spooncer E., Dexter TM, Taylor DR (1990). Hematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature343:75-76.
183.
Wingo P., Tong T., Bolden S. (1995). Cancer statistics, 1995. CA Cancer J Clin45:8-30.
184.
Yanaga F., Watson SP (1992). Tumor necrosis factor a stimulates sphingomyelinase through the 55 kD receptor in HL-60 cells. FEBS Lett314:297-300.
185.
Yao R., Cooper GM (1993). Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science267:2003-2006.
186.
Yarden Y., Schlessinger J. (1987). Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochem26:1434-1442.
187.
Yarden Y., Ullrich A. (1988). Growth factor receptor tyrosine kinases. Ann Rev Biochem57:443-478.
188.
Yasumura S., Lin WC, Weidmann E., Hebda P., Whiteside TL (1994). Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2. Int J Cancer59:225-234.
189.
Yin D., Kondo S., Barnett GH, Morimura T., Takeuchi J. (1995). Tumor necrosis factor-alpha induces p53-dependent apoptosis in rat glioma cells. Neurosurg37:758-762.
190.
Yin XM, Oltvai ZN, Korsmeyer S.) (1995). Heterodimerization with Bax is required for Bcl-2 to repress cell death. CurrTop Microbiol Immunol194:331-338.
191.
Yoshimura A., Longmore G., Lodish HF (1990). Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone independent activation and tumorigenicity. Nature348:647-649.
192.
Zariwala M., Schmid S., Pfaltz M., Ohgaki H., Kleihues P., Schafer R. (1994). p53 gene mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumours and lymph-node metastases. Int J Cancer56:807-811.
193.
Zhang W., Dziak RM, Aletta JM (1995). EGF-mediated phosphorylation of extracellular signal-regulated kinases in osteoblastic cells. J Cell Physiol162:348-358.
